NovaBridge Biosciences Research And Development Expense

• NovaBridge Biosciences showed an increase of +1.5% in Research And Development Expense from 2023 to 2024.
• This data is from NovaBridge Biosciences's annual report (Form 10-K), filed with the SEC on April 3, 2025.
• XBRL data for this metric is available from 2010 to 2024 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2010 to 2024), NovaBridge Biosciences's Research And Development Expense has declined by 50.1%.
• Historical annual values: Fiscal year 2024: $21.77 million | Fiscal year 2023: $21.45 million | Fiscal year 2022: $22.55 million | Fiscal year 2021: $1.21 billion | Fiscal year 2020: $984.69 million | Fiscal year 2019: $840.42 million | Fiscal year 2018: $426.03 million | Fiscal year 2017: $267.08 million | Fiscal year 2010: $43.60 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026